Cleveland Clinic

Pauline Funchain, MD, highlights how humility may be one of the best characteristics in medicine right now.

Daniel Ontaneda, MD, provides insight into the implications of discovering a new subtype of multiple sclerosis: myelocortical MS.

Bruce Trapp, PhD, discusses his team’s recent discovery of a new subtype of multiple sclerosis: myelocortical MS.

One Cleveland Clinic practitioner describes his real-world experience with the use of mepolizumab in patients with severe eosinophilic asthma.

A team of investigators at Cleveland Clinic discover a novel subtype of multiple sclerosis which features neuronal loss but no demyelination of the brain’s white matter.

Cleveland Clinic investigators have discovered a novel form of the neurological condition which does not demyelinate the brain's white matter.

The Cleveland Clinic’s pioneer of minority programs plans to end health disparity.

Steve Case is on a mission to save healthcare, and he intends to do it by harnessing the consumer-empowering capabilities of the Internet.

On October 18-20, 2004, hundreds of top-level executives from the medical device, biotech, and pharmaceutical industries, entrepreneurs and investors from all across the globe, and thought leaders...